Cervical Radiculopathy Trial

Not Applicable

Active, not recruiting

• Conditions: Cervical Radiculopathy
• Interventions: Procedure: Anterior discectomy; Behavioral: Conservative treatment

• Registration Number: NCT03674619
• Lead Sponsor: Oslo University Hospital

Brief Summary

The primary aim of the present project is to compare the effectiveness of surgery and nonsurgical treatment in patients with cervical radiculopathy caused by either disc herniation or spondylosis. Secondary aims are to evaluate cost-effectiveness and predicting factors of success of the two treatments, and to explore the terms success rate and expectations by asking the patients to fill in their expected primary outcome score at baseline.

Detailed Description

Cervical radiculopathy is usually caused by disc herniation or spondylosis. Prognosis is expected to be good in most patients but there is limited scientific evidence about the indication for non-surgical and surgical treatment.

Two randomised controlled trials comparing cervical decompression and non-operative treatment with cost-effectiveness analysis and assessment of expectations and predictors of outcome. The main research question will be evaluated at one-year follow-up.

1. To test the hypothesis that the effectiveness of surgery as measured by the change in Neck Disability Index (NDI) at 1-year follow-up in patients with cervical radiculopathy is not different from non-surgical treatment in:

1. Study 1: one level disc herniation (C5/6 or C6/7)

2. Study 2: one or two level spondylosis (C5/6 and/or C6/7)

2. To test the hypothesis that surgery is more effective in patients with more clinical finding (dermatomal sensory loss, myotonal weakness and reflex disturbance) at baseline when adjusted for other possible predictors such as age, gender, baseline pain, duration, radiological findings, expectations, and psychological factors).

3. To estimate cost-effectiveness for health care costs and societal costs (including sickness absence) in surgical versus non-surgical patients.

4. To assess radiological (MRI and CT) measurements of foraminal area and nerve compression and if changes can predict clinical changes (NDI and arm pain) at 1-year .

5. To evaluate treatment outcome expectations at baseline asking the patients to fill in their expected improvement.

Study Timeline

• Study First Submitted: 2018-09-14
• Study First Submitted QC: 2018-09-14
• Study First Posted: 2018-09-17
• Study Start: 2018-10-19
• Status Verified: 2024-12
• Last Update Submitted: 2024-12-13
• Last Update Posted: 2024-12-19
• Primary Completion: 2028-01-31
• Study Completion: 2028-01-31

Recruitment & Eligibility

• Status: ACTIVE_NOT_RECRUITING
• Sex: All
• Target Recruitment: 180

Inclusion Criteria

• Age 20 to 65 years.
• Study 1: Neck and arm pain for at least 3 months with a corresponding herniation involving one cervical nerve root (C6 or C7) Study 2: Neck and arm pain for at least 3 months with a corresponding spondylosis involving C6 and/or C7) .
• Pain intensity of arm pain of at least 4 on a scale from 0 (no pain) to 10 (worst possible pain)
• Willing to accept either of the treatment alternatives
• NDI > 30

Exclusion Criteria

• Patients with any previous cervical fractures or cervical spine surgery;
• Signs of myelopathy;
• Rapidly progressive paresis or paresis < grade 4;
• Pregnancy;
• Arthritis involving the cervical spine;
• Infection or active cancer;
• Generalised pain syndrome;
• Serious psychiatric or somatic disease that exclude one of the treatment alternatives;
• Concomitant shoulder disorders that may interfere with outcome;
• Abuse of medication/narcotics,
• Not able to understand written Norwegian,
• Not willing to accept one of the treatment alternatives.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Surgical treatment	Anterior discectomy	Anterior discectomy
Conservative treatment	Conservative treatment	Patients will attend an experienced specialist in physical medicine and rehabilitation and a physiotherapist.

Primary Outcome Measures

Name	Time	Method
Neck Disability Index	Follow-up at 52 weeks is the primary end point.	Consists of ten questions about pain related disability and include items such as by example headache, concentration, reading and sleep. Each item is rated by choosing one of five response categories and transformed to a total score from 0 to 100 (worst possible). The Norwegian version has been validated in patients with neck pain and with cervical radiculopathy.

Secondary Outcome Measures

Name	Time	Method
Neck pain	52 weeks	Neck pain measured by Numeric Rating Scale (NRS) from 0 (no pain to 10 (worst imaginable pain).
EuroQol (EQ-5D-5L and EQ-VAS)	52 weeks	EQ-5D-5L includes five domains: mobility; self-care, daily activities, pain/discomfort, and anxiety/depression and each has three response categories. The responses are transformed into and index to value the patients' health related quality of life for the cost utility analyses. Patients score their health from 0 (as bad as possible) to 100 (best possible) by EQ-VAS. The Norwegian version has been validated in patients with back pain, idiopathic scoliosis, and cervical radiculopathy.
Fear-avoidance beliefs	52 weeks	Evaluated with the Fear Avoidance Beliefs Questionnaire
Emotional distress	52 weeks	Assessed by the 10-question version of the Hopkins Symptom Check List
Perceived recovery	52 weeks	Perceived recovery or change of the main symptom rated on a numeric scale ranging from -9 (worst possible change) to 9 (best possible change)
Sickness absence data	52 weeks	Sickness absence data will be collected from the National Social Security Institution for the year before and after inclusion.
Dysphagia	52 weeks	As recorded by The Dysphagia Short Questionnaire
Medicine consumption	52 weeks	Questions related to pain medication usage.
Patient expectations	At inclusion	Exploring patient expectations ahead of treatment. The patients are asked to fill out the Neck Disability Index pretending they are at 52 weeks post treatment and selecting the lowest category they would be content with for each item. The patients are also asked to report what they expect their symptoms to be like 52 weeks ahead (ranging from much worse to much better), registered for arm pain, neck pain and headache separately.
Success rate	52 weeks	Exploring global success rate by asking the patients about how the arm pain and neck pain is compared to prior to treatment (ranging from much worse to much better).
Arm pain	52 weeks	Arm pain measured by Numeric Rating Scale (NRS) from 0 (no pain to 10 (worst imaginable pain).

Trial Locations

Locations (1)

Oslo University Hospital; 🇳🇴 Oslo, Norway